US Patent Issued to TIANJIN CONJUSTAR BIOLOGICS on Aug. 5 for "Radionuclide labeled polypeptide conjugates and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,177, issued on Aug. 5, was assigned to TIANJIN CONJUSTAR BIOLOGICS Co. LTD. (Tianjin, China).

"Radionuclide labeled polypeptide conjugates and uses thereof" was invented by Shuyi Tang (Tianjin, China), Cheng Xie (Tianjin, China) and Zhiping Cui (Tianjin, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a radioactive polypeptide conjugate drug and for use thereof in nuclear medicine as a tracer, an imaging agent, and for treating various disease states associated with tumors is provided."

The patent was filed on April 26, 2024, under Application No. 18/646,785.

*For further information, including images, charts ...